Oaktree Acquisition Corp. II and Alvotech Complete Business Combination to List on Nasdaq as ALVO

June 15, 2022

Alvotech completed its business combination with Oaktree Acquisition Corp. II, a SPAC sponsored by an affiliate of Oaktree Capital Management, resulting in a Nasdaq listing under ticker symbols ALVO/ALVOW. The deal included a ~$175 million upsized, fully committed PIPE at $10.00 per share and was designed to create a publicly traded, pure-play global biosimilars platform.

Buyers
Oaktree Acquisition Corp. II, Oaktree Capital Management, L.P. (via SPAC sponsor affiliate)
Targets
Alvotech Holdings S.A.
Industry
Biotechnology
Location
Iceland
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.